Insomnia is a common comorbidity among adolescents with migraine. This randomized controlled clinical trial aims to determine efficacy of cognitive-behavioral therapy (CBT) for insomnia, as well as the combined effect of CBT insomnia and pain interventions, on reducing insomnia symptoms and headache-related disability in adolescents with migraine. The long-term goal is to offer effective, tailored self-management interventions that can address migraine and co-morbid sleep problems in adolescence and disrupt a cycle of persistent, disabling migraine from continuing into adulthood.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in insomnia symptoms
Timeframe: Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in headache-related disability
Timeframe: Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up